Susan M Goodman1, Lisa A Mandl1, Mark Figgie2, Beverly K Johnson1, Michael Alexiades2, Hassan Ghomrawi3. 1. Division of Rheumatology, Weill Cornell Medical College, New York, NY 10065 USA ; Division of Rheumatology, Hospital for Special Surgery, 535 East 70th St, New York, NY 10021 USA. 2. Department of Orthopedic Surgery, Weill Cornell Medical College, New York, NY 10065 USA ; Department of Orthopedic Surgery, Hospital for Special Surgery, 535 East 70th St, New York, NY 10021 USA. 3. Division of Health Policy, Weill Cornell Medical College, New York, NY USA ; Hospital for Special Surgery, 535 East 70th Street, New York, NY USA.
Abstract
BACKGROUND: Preoperative expectations of total knee arthroplasty (TKA) correlate with postsurgical satisfaction, and are linked to outcomes. Rheumatoid arthritis (RA), and other chronic diseases, may lower expectations, although new biologic medications have greatly enhanced patients' quality of life. QUESTIONS/PURPOSES: The purpose of this study is to compare preoperative expectations of RA to those of matched osteoarthritis (OA) patients undergoing TKA, and examine the subset of RA on biologic DMARD therapy. METHODS: For a cross-sectional study, RA and OA identified from an institutional TKA registry were matched on age, sex, prior TKA, and preoperative function. Expectations were measured using the Hospital for Special Surgery (HSS) Knee Expectations Survey. Expectations and quality of life measures were assessed preoperatively and scores were compared between RA and OA. RESULTS: One hundred fourteen RA cases, 46.5% on biologics, were matched to 228 OA cases. The average expectations score was not significantly lower for RA compared to OA (72.9 ± 20.7 vs. 77.2 ± 18.3, p = 0.040. RA on biologics had expectations similar to OA (total expectation score 76.3 ± 18.1 vs. 77.4 ± 17.4, p = 0.71), while RA not on biologics had expectations that were significantly lower (69.9 ± 22.4 vs. 77.1 ± 19.0, p = 0.03). CONCLUSION: Use of biologics in RA patients was associated with higher expectations, similar to those of OA patients, but the effect on outcomes is not known. Further studies should assess the effect of higher expectations in RA patients on outcomes.
BACKGROUND: Preoperative expectations of total knee arthroplasty (TKA) correlate with postsurgical satisfaction, and are linked to outcomes. Rheumatoid arthritis (RA), and other chronic diseases, may lower expectations, although new biologic medications have greatly enhanced patients' quality of life. QUESTIONS/PURPOSES: The purpose of this study is to compare preoperative expectations of RA to those of matched osteoarthritis (OA) patients undergoing TKA, and examine the subset of RA on biologic DMARD therapy. METHODS: For a cross-sectional study, RA and OA identified from an institutional TKA registry were matched on age, sex, prior TKA, and preoperative function. Expectations were measured using the Hospital for Special Surgery (HSS) Knee Expectations Survey. Expectations and quality of life measures were assessed preoperatively and scores were compared between RA and OA. RESULTS: One hundred fourteen RA cases, 46.5% on biologics, were matched to 228 OA cases. The average expectations score was not significantly lower for RA compared to OA (72.9 ± 20.7 vs. 77.2 ± 18.3, p = 0.040. RA on biologics had expectations similar to OA (total expectation score 76.3 ± 18.1 vs. 77.4 ± 17.4, p = 0.71), while RA not on biologics had expectations that were significantly lower (69.9 ± 22.4 vs. 77.1 ± 19.0, p = 0.03). CONCLUSION: Use of biologics in RApatients was associated with higher expectations, similar to those of OA patients, but the effect on outcomes is not known. Further studies should assess the effect of higher expectations in RApatients on outcomes.
Authors: Lazaros A Poultsides; Hassan M K Ghomrawi; Stephen Lyman; Gina B Aharonoff; Carol A Mancuso; Thomas P Sculco Journal: J Arthroplasty Date: 2012-04-03 Impact factor: 4.757
Authors: Loreto Massardo; Sherine E Gabriel; Cynthia S Crowson; W Michael O'Fallon; Eric L Matteson Journal: J Rheumatol Date: 2002-01 Impact factor: 4.666
Authors: C A Mancuso; T P Sculco; T L Wickiewicz; E C Jones; L Robbins; R F Warren; P Williams-Russo Journal: J Bone Joint Surg Am Date: 2001-07 Impact factor: 5.284
Authors: Carol A Mancuso; Suzanne Graziano; Lisa M Briskie; Margaret G E Peterson; Paul M Pellicci; Eduardo A Salvati; Thomas P Sculco Journal: Clin Orthop Relat Res Date: 2008-01-10 Impact factor: 4.176
Authors: Yi Ren; Qi Yang; Xisheng Weng; Bin Feng; Tim Luo; Jin Lin; Jin Jin; Wenwei Qian Journal: J Orthop Surg Res Date: 2021-01-27 Impact factor: 2.359